Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peter Crooks
Univ of Arkansas for Med Scis, Department: Pharmacology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Leuchemix, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Investigator holds an equity interest in Leuchemix, Inc., a company that researches and develops compounds for the treatment of leukemia and solid tumors. Investigator is also one of the inventors of the Technology (five patent applications relating to derivatives of Parthenolides and Melampomagnolides) licensed to Leuchemix, Inc. that will be used or evaluated by this study. Leuchemix and the Investigator have potential for financial gain based on the outcomes of this study.
Novel melampomagnolide B-based prodrugs for the treatment of leukemia
The goal of this project is to identify new and better ways to treat leukemia. We propose to develop new drugs derived from the naturally occurring compound parthenolide, which has shown significant activity as an anti-leukemia agent. Our studies will synthesize and test novel orally-available parthenolide derivatives
Filed on October 12, 2015.
Tell us what you know about Peter Crooks's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Peter Crooks filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Peter Crooks | Univ of Arkansas for Med Scis | Conflict of Interest | Leuchemix, Inc. | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.